[{"address1": "8 Zhongtian Street", "address2": "Suzhou Industrial Park", "city": "Suzhou", "zip": "215028", "country": "China", "phone": "86 512 8187 7166", "website": "https://www.peijiamedical.com", "industry": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Peijia Medical Limited engages in the research and development of transcatheter valve therapeutic and neuro interventional procedural medical devices. Its transcatheter valve therapeutic products include TaurusOne, a transcatheter aortic valve replacement (TAVR) system; TaurusElite, a retrievable TAVR system; TaurusNXT, a non-glutaraldehyde crosslinking dry-tissue TAVR system; TaurusMax, an iteration steerable TAVR system; TaurusTrio, a TAVR system; TaurusWave, a lithotripsy valvuloplasty system; TaurusApex, a polymeric leaflet TAVR system; Trilogy, a TAVR System; HighLife, a transseptal mitral value replacement system; Sutra Hemi Valve, a TMV coaptation augmentation system; GeminiOne, a transcatheter edge-to-edge repair system; MonarQ which is transcatheter tricuspid valve replacement systems; TaurusAtlas, a transfemoral balloon catheter; TaurusExplora, a pre-shaped guidewire; and TaurusNavi, an introducer sheath. The company also offers Jasper and Presgo, that are detachable coils; Jasper SS detachable coil; intracranial adjunctive stents; SacSpeed, a balloon dilatation catheter; Tethys AS, an aspiration catheter; Syphonet, a stent retriever; Fastunnel, a balloon microcatheter; Fluxcap, a balloon guiding catheter; NeuroStellar, an intracranial stent; Presgo microcatheter and micro guidewire; Heralder guiding catheter and distal access catheter; Tethys, an intermediate catheter; and Jasper power supply. In addition, it engages in the trading business. Peijia Medical Limited was incorporated in 2012 and is headquartered in Suzhou, the People's Republic of China.", "fullTimeEmployees": 1050, "companyOfficers": [{"maxAge": 1, "name": "Dr. Yi  Zhang", "age": 55, "title": "Chairman & CEO", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 204910, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Leo  Tsai", "age": 41, "title": "Chief Financial Officer", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kongrong  Pan", "age": 64, "title": "Chief Operating Officer", "yearBorn": 1959, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Fong Tan  Jian", "age": 47, "title": "Chief Technology Officer", "yearBorn": 1976, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ping Ye  Zhang", "age": 55, "title": "Executive Director", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 25544, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hong  Ye", "age": 51, "title": "Executive Director & Company Secretary", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 105121, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Xiaoxiao  Zhuang", "age": 40, "title": "Vice President of Sales", "yearBorn": 1983, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hongpeng  Wang", "age": 42, "title": "Vice President of Marketing", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hing Ling  Chau FCIS, FCS, L.L.M.", "age": 48, "title": "Company Secretary", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "open": 1.3867, "dayLow": 1.3867, "dayHigh": 3.5, "regularMarketOpen": 1.3867, "regularMarketDayLow": 1.3867, "regularMarketDayHigh": 3.5, "beta": 0.578, "volume": 76000, "regularMarketVolume": 76000, "bid": 0.51, "ask": 500.0, "marketCap": 921740864, "fiftyTwoWeekLow": 1.3867, "fiftyTwoWeekHigh": 3.5, "priceToSalesTrailing12Months": 1.7812864, "fiftyDayAverage": 1.3867, "twoHundredDayAverage": 1.3867, "trailingAnnualDividendYield": "NaN", "currency": "USD", "enterpriseValue": 269453312, "profitMargins": -0.48648998, "floatShares": 449352213, "sharesOutstanding": 664700992, "heldPercentInsiders": 0.29368, "heldPercentInstitutions": 0.38604, "bookValue": 3.211, "priceToBook": 0.43185925, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -251736992, "trailingEps": -0.11, "enterpriseToRevenue": 0.521, "enterpriseToEbitda": -1.162, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "PEJMF", "underlyingSymbol": "PEJMF", "shortName": "PEIJIA MEDICAL LIMITED", "longName": "Peijia Medical Limited", "firstTradeDateEpochUtc": 1673620200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "4751499f-9cf4-389d-a238-f2136d0ba41d", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.3867, "recommendationKey": "none", "totalCash": 925297984, "totalCashPerShare": 1.362, "ebitda": -231911504, "totalDebt": 252700000, "quickRatio": 5.89, "currentRatio": 7.01, "totalRevenue": 517457984, "debtToEquity": 11.585, "revenuePerShare": 0.761, "returnOnAssets": -0.06197, "returnOnEquity": -0.10885, "revenueGrowth": 0.339, "grossMargins": 0.7175, "ebitdaMargins": -0.44817, "operatingMargins": -0.28607, "financialCurrency": "CNY", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]